| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38180095A | 1995-02-01 | 1995-02-01 | |
| US381800 | 1995-02-01 | ||
| PCT/US1995/009589WO1996023899A1 (en) | 1995-02-01 | 1995-07-27 | Methods of selecting a random peptide that binds to a target protein |
| Publication Number | Publication Date |
|---|---|
| AU3204895Atrue AU3204895A (en) | 1996-08-21 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU32048/95AAbandonedAU3204895A (en) | 1995-02-01 | 1995-07-27 | Methods of selecting a random peptide that binds to a target protein |
| Country | Link |
|---|---|
| AU (1) | AU3204895A (en) |
| WO (1) | WO1996023899A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6365344B1 (en) | 1996-01-23 | 2002-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
| DK0877752T3 (en)* | 1996-01-23 | 2003-09-15 | Univ Leland Stanford Junior | Methods for screening transdominant effector peptides and RNA molecules |
| GB9701425D0 (en)* | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
| DE19805334A1 (en)* | 1998-02-11 | 1999-08-12 | Otogene Biotechnologische Fors | Process for the development of an active pharmaceutical ingredient |
| EP0972780A1 (en)* | 1998-05-18 | 2000-01-19 | Applied Research Systems ARS Holding N.V. | Il-6 antagonist peptides |
| PT2319928E (en) | 1998-10-23 | 2013-06-28 | Kirin Amgen Inc | Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
| US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| EP1278778A2 (en)* | 2000-05-03 | 2003-01-29 | Amgen Inc., | Modified peptides, comprising an fc domain, as therapeutic agents |
| FR2860237B1 (en) | 2003-09-30 | 2006-03-10 | Centre Nat Rech Scient | INTERACTION POLYPEPTIDE COMPRISING A HEPTAPEPTIDE PATTERN AND A CELL PENETRATION DOMAIN |
| CA2580796C (en) | 2004-09-24 | 2013-03-26 | Amgen Inc. | Modified fc molecules having peptides inserted in internal loop regions |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| AU2019405925B2 (en) | 2018-12-20 | 2025-07-03 | KSQ Therapeutics, Inc. | Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors |
| MX2023004937A (en) | 2020-10-30 | 2023-05-17 | Ksq Therapeutics Inc | Solid state forms of substituted pyrazolopyrimidines and uses thereof. |
| WO2023066881A1 (en) | 2021-10-18 | 2023-04-27 | Astrazeneca Ab | Inhibition of map3k15 for treating and preventing diabetes |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en)* | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5723286A (en)* | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
| Publication number | Publication date |
|---|---|
| WO1996023899A1 (en) | 1996-08-08 |
| Publication | Publication Date | Title |
|---|---|---|
| AU6311996A (en) | Peptide inhibitors of fibronectine | |
| AU3204895A (en) | Methods of selecting a random peptide that binds to a target protein | |
| AU5956196A (en) | Methods of increasing accumulation of essential amino acids n seeds | |
| AU7566396A (en) | Process for the preparation of peptides by way of streptavidin fusion proteins | |
| AU5324996A (en) | Protein kinase c inhibitors | |
| AU7516694A (en) | Biotinylation of proteins | |
| AU7631496A (en) | Substituted 2-anilinopyrimidines useful as protein kinase inhibitors | |
| AU6046696A (en) | Peptides and compounds that bind to a receptor | |
| AU7317496A (en) | Activation of p53 protein | |
| AU5289596A (en) | Peptide suppressing ixbalpha phosphorylation | |
| AU4953796A (en) | Dipeptide compounds having ahpba structure | |
| AU4394396A (en) | Modified peptides | |
| AU6873596A (en) | Allergen-xcd32 fusion proteins | |
| AU7727996A (en) | Excitatory amino acid derivatives | |
| AU7294396A (en) | Protein detection | |
| AU5532796A (en) | Pharmaceutical preparations derived from korean mistletoe | |
| EP0831878A4 (en) | Novel peptide inhibitors of calmodulin | |
| AU5550296A (en) | Conotoxin peptides | |
| AU6052696A (en) | Modified heel valve construction | |
| AU5440596A (en) | Inhibiting degradation of a degron-bearing protein | |
| AU7520396A (en) | Abl-interactor protein | |
| AU2365795A (en) | Multiple administrations of anti-tnf antibody | |
| AU1117597A (en) | Huntingtin-associated protein | |
| AU5284296A (en) | Immune-evading proteins | |
| AU6890696A (en) | Peptide derivatives |